Mineralys Therapeutics Inc (NAS:MLYS)
$ 25.65 -0.10 (-0.39%) Market Cap: 2.27 Bil Enterprise Value: 1.61 Bil PE Ratio: 0 PB Ratio: 4.11 GF Score: 33/100